NCT01382537

Brief Summary

This study will focus on the efficacy of treating 80 patients who have functional limitations in activity because of chronic/recurrent neck or shoulder pain. Hypothesis 1: InterX therapy alone will have a moderate effect to reduce pain during weeks 1-2. Hypothesis 2: Functional gains will be greater in patients receiving InterX therapy compared to those who received placebo treatment. Hypothesis 3: Chronic neck and shoulder pain is more prevalent in patients who exhibit radiographic evidence of degenerative spondylosis/arthrosis of the cervical spine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 21, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

June 27, 2011

Completed
Last Updated

July 25, 2014

Status Verified

July 1, 2014

Enrollment Period

2.2 years

First QC Date

September 21, 2009

Last Update Submit

July 24, 2014

Conditions

Keywords

NeckChronicMusculoskeletalShoulder

Outcome Measures

Primary Outcomes (8)

  • Visual Analog Scale

    Pain scores on the Visual Analog Scale.

    10 minutes

  • Neck Disability Index

    Neck Disability Index pain scores.

    15 minutes

  • Shoulder Pain and Disability Index

    Shoulder Pain and Disability Index scores.

    60 minutes

  • Medical Outcomes Study Short-Form (SF-36)

    Change in Medical Outcomes Study Short-Form (SF-36) score.

    15 minutes

  • Neck Walk Index

    Change in Neck Walk Index score.

    20 minutes

  • Upper Limb Coordination During and Overhead Reach

    Change in range of motion.

    20 minutes

  • Task Limitation (TL)/Upper Limb Function - FIT-HaNSA Protocol

    Change in FIT-HaNSA score.

    20 min

  • EMG testing

    Mean frequency shifts. Change in percentage of maximum voluntary contraction.

    30 minutes

Secondary Outcomes (1)

  • Blood and serum biomarkers

    20 minutes

Study Arms (2)

A

ACTIVE COMPARATOR
Device: InterX 5000

B

PLACEBO COMPARATOR
Device: InterX 5000

Interventions

A computer driven electrical stimulation unit that contains a cutaneous impedance sensor.

A

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • males or females
  • ages 18-65
  • chronic or recurrent neck or shoulder pain
  • pain of at least 3 months duration
  • willing to sign consent form
  • able/willing to comply with treatment schedule

You may not qualify if:

  • age over 65 years
  • clinically significant herniated disc
  • spinal fracture
  • previous electrical stimulation treatment for this episode
  • recent cervical spine or shoulder surgery
  • implanted instrumentation/prostheses
  • epilepsy
  • pregnancy
  • recent (3 months) chemotherapy/radiotherapy
  • phlebitis
  • cortisone use (30 days)
  • hypersensitivity to tape used with EMG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Canadian Memorial Chiropractic College

Toronto, Ontario, Canada

Location

Related Publications (6)

  • Brennan PC, Triano JJ, McGregor M, Kokjohn K, Hondras MA, Brennan DC. Enhanced neutrophil respiratory burst as a biological marker for manipulation forces: duration of the effect and association with substance P and tumor necrosis factor. J Manipulative Physiol Ther. 1992 Feb;15(2):83-9.

    PMID: 1373431BACKGROUND
  • Godfrey CM, Morgan PP, Schatzker J. A randomized trial of manipulation for low-back pain in a medical setting. Spine (Phila Pa 1976). 1984 Apr;9(3):301-4. doi: 10.1097/00007632-198404000-00015.

    PMID: 6233718BACKGROUND
  • Hurley DA, McDonough SM, Dempster M, Moore AP, Baxter GD. A randomized clinical trial of manipulative therapy and interferential therapy for acute low back pain. Spine (Phila Pa 1976). 2004 Oct 15;29(20):2207-16. doi: 10.1097/01.brs.0000142234.15437.da.

    PMID: 15480130BACKGROUND
  • Pope MH, Phillips RB, Haugh LD, Hsieh CY, MacDonald L, Haldeman S. A prospective randomized three-week trial of spinal manipulation, transcutaneous muscle stimulation, massage and corset in the treatment of subacute low back pain. Spine (Phila Pa 1976). 1994 Nov 15;19(22):2571-7. doi: 10.1097/00007632-199411001-00013.

    PMID: 7855683BACKGROUND
  • Teodorczyk-Injeyan JA, Injeyan HS, Ruegg R. Spinal manipulative therapy reduces inflammatory cytokines but not substance P production in normal subjects. J Manipulative Physiol Ther. 2006 Jan;29(1):14-21. doi: 10.1016/j.jmpt.2005.10.002.

    PMID: 16396725BACKGROUND
  • Teodorczyk-Injeyan JA, Triano JJ, McGregor M, Woodhouse L, Injeyan HS. Effect of Interactive Neurostimulation Therapy on Inflammatory Response in Patients With Chronic and Recurrent Mechanical Neck Pain. J Manipulative Physiol Ther. 2015 Oct;38(8):545-54. doi: 10.1016/j.jmpt.2015.08.006. Epub 2015 Oct 4.

MeSH Terms

Conditions

Neck PainShoulder PainBronchiolitis Obliterans Syndrome

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsArthralgiaJoint DiseasesMusculoskeletal DiseasesOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. John J. Triano

Study Record Dates

First Submitted

September 21, 2009

First Posted

June 27, 2011

Study Start

January 1, 2008

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

July 25, 2014

Record last verified: 2014-07

Locations